Cargando…

Improving adherence to endocrine hormonal therapy among breast cancer patients: Study protocol for a randomized controlled trial

Adjuvant endocrine hormonal therapy (EHT) is highly effective and appropriate for nearly all breast cancer patients with hormone receptor-positive tumors, which represent 75% of all breast cancer diagnoses. Long-term use of EHT reduces recurrence rates and nearly halves the risk of death during the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chalela, P., Munoz, E., Inupakutika, D., Kaghyan, S., Akopian, D., Kaklamani, V., Lathrop, K., Ramirez, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202663/ https://www.ncbi.nlm.nih.gov/pubmed/30377674 http://dx.doi.org/10.1016/j.conctc.2018.10.001

Ejemplares similares

Direct Outreach in Bars and Clubs to Enroll Cigarette Smokers in Mobile Cessation Services: Exploratory Study
por: Chalela, Patricia, et al.
Publicado: (2022)

A Digital Health Intervention for Weight Management for Latino Families Living in Rural Communities: Perspectives and Lessons Learned During Development
por: Yin, Zenong, et al.
Publicado: (2020)

Adherence to Adjuvant Endocrine Therapy in Breast Cancer Patients
por: Rosso, Roberta, et al.
Publicado: (2023)

THRIVE study protocol: a randomized controlled trial evaluating a web-based app and tailored messages to improve adherence to adjuvant endocrine therapy among women with breast cancer
por: Paladino, Andrew J., et al.
Publicado: (2019)

Randomized phase III trial evaluating motivational interviewing and text interventions to optimize adherence to breast cancer endocrine therapy (Alliance A191901): the GETSET protocol
por: Ivory, Joannie, et al.
Publicado: (2023)

Breast Nurse Intervention to Improve Adherence to Endocrine Therapy Among Breast Cancer Patients in South Ethiopia
por: Getachew, Sefonias, et al.
Publicado: (2022)

Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer
por: D’Souza, Anishka, et al.
Publicado: (2018)

Adherence to endocrine therapy among Chinese patients with breast cancer: current status and recommendations for improvement
por: Gao, Pin, et al.
Publicado: (2018)

Adherence evaluation of endocrine treatment in breast cancer: methodological aspects
por: Oberguggenberger, Anne S, et al.
Publicado: (2012)

Improving adherence to web-based cessation programs: a randomized controlled trial study protocol
por: Graham, Amanda L, et al.
Publicado: (2013)

Exogenous Hormonal Regulation in Breast Cancer Cells by Phytoestrogens and Endocrine Disruptors
por: Albini, A., et al.
Publicado: (2014)

Pharmacist Interventions to Improve Specialty Medication Adherence: Study Protocol for a Randomized Controlled Trial
por: Kibbons, Amanda M., et al.
Publicado: (2020)

E2112: randomized phase iii trial of endocrine therapy plus entinostat/placebo in patients with hormone receptor-positive advanced breast cancer
por: Yeruva, Sri Lakshmi Hyndavi, et al.
Publicado: (2018)

Endocrine Therapy for Breast Cancer: A Model of Hormonal Manipulation
por: Johnston, Simon J., et al.
Publicado: (2018)

Relationships between determinants of adjuvant endocrine therapy adherence in breast cancer
por: Lee, Joo Yun, et al.
Publicado: (2018)

Refining and optimising a behavioural intervention to support endocrine therapy adherence (ROSETA) in UK women with breast cancer: protocol for a pilot fractional factorial trial
por: Smith, Samuel G, et al.
Publicado: (2023)

Oncologists’ perspectives on adherence/non-adherence to adjuvant endocrine therapy and management strategies in women with breast cancer
por: Eraso, Yolanda
Publicado: (2019)

Systematic adaptation of the adherence improving self‐management strategy to support breast cancer survivors' adherence to adjuvant endocrine therapy: An intervention mapping approach
por: Janssen, Anna M., et al.
Publicado: (2022)

Intermittent Use of Anti-Hormonal Agents for the Endocrine Therapy of Sex-Hormone-Dependent Breast and Prostate Cancer: A Protocol for a Systematic Review
por: Kesztyüs, Dorothea, et al.
Publicado: (2022)

Hormone Production in Endocrine Tumours
por: Abelson, Denis
Publicado: (1958)

Racial Differences in Patient-Reported Symptoms and Adherence to Adjuvant Endocrine Therapy Among Women With Early-Stage, Hormone Receptor–Positive Breast Cancer
por: Hu, Xin, et al.
Publicado: (2022)

Extended adjuvant endocrine therapy for women with hormone receptor-positive early breast cancer: A meta-analysis with trial sequential analysis of randomized controlled trials
por: Xie, Ming, et al.
Publicado: (2022)

Endocrinology and hormone therapy in breast cancer: Endocrine therapy in premenopausal women
por: Pritchard, Kathleen
Publicado: (2005)

Impact of Chemical Endocrine Disruptors and Hormone Modulators on the Endocrine System
por: Guarnotta, Valentina, et al.
Publicado: (2022)

Pituitary Hormones and Orofacial Pain
por: Dussor, Gregory, et al.
Publicado: (2018)

Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality
por: Makubate, B, et al.
Publicado: (2013)

Beliefs about medicines and adherence in women with breast cancer on adjuvant endocrine therapy
por: Tan, Eng Hooi, et al.
Publicado: (2021)

Healthcare Provider Perspectives on Adherence to Adjuvant Endocrine Therapy after Breast Cancer
por: Lambert, Leah K., et al.
Publicado: (2021)

Randomized Embolization Trial for NeuroEndocrine Tumor Metastases to the Liver (RETNET): study protocol for a randomized controlled trial
por: Chen, James X., et al.
Publicado: (2018)

Development of the HT&Me intervention to support women with breast cancer to adhere to adjuvant endocrine therapy and improve quality of life
por: Stewart, Sarah-Jane F., et al.
Publicado: (2023)

Optimum duration of extended adjuvant endocrine therapy in patients with hormone receptor-positive breast cancer: protocol for a network meta-analysis of randomised controlled trials
por: Hu, Qiancheng, et al.
Publicado: (2023)

Study protocol for a randomised controlled feasibility trial of a virtual intervention (STRIDE) for symptom management, distress and adherence to adjuvant endocrine therapy after breast cancer
por: Jacobs, Jamie M, et al.
Publicado: (2021)

Safety of adjuvant endocrine therapies in hormone receptor–positive early breast cancer
por: Sehdev, S., et al.
Publicado: (2009)

Endocrine Resistance in Hormone Receptor Positive Breast Cancer–From Mechanism to Therapy
por: Rani, Aradhana, et al.
Publicado: (2019)

Adherence to hormone therapy among women with breast cancer
por: Brito, Claudia, et al.
Publicado: (2014)

Determinants of non-adherence to adjuvant endocrine treatment in women with breast cancer: the role of comorbidity
por: Wulaningsih, W., et al.
Publicado: (2018)

Self-Reported Adherence to Oral Endocrine Therapy among Breast Cancer Patients in Jordan
por: Faqeer, Nour, et al.
Publicado: (2022)

Neuro-immune-endocrine mechanisms with poor adherence to aromatase inhibitor therapy in breast cancer
por: Huifang, Li, et al.
Publicado: (2022)

Importance of endocrine treatment adherence and persistence in breast cancer survivorship: a systematic review
por: Eliassen, Finn Magnus, et al.
Publicado: (2023)

Hormonal treatments for endometriosis: The endocrine background
por: Vannuccini, Silvia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kr9m9tgbra8ci6vl29m35o3pfb